# Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder

> **NCT00583193** · PHASE3 · UNKNOWN · sponsor: **Canive, Jose M., M.D.** · enrollment: 20 (estimated)

## Conditions studied

- Posttraumatic Stress Disorders

## Interventions

- **DRUG:** Duloxetine hydrochloride

## Key facts

- **NCT ID:** NCT00583193
- **Lead sponsor:** Canive, Jose M., M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2008-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2007-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00583193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00583193, "Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00583193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*